Logo image of CRDO

CREDO TECHNOLOGY GROUP HOLDI (CRDO) Stock Fundamental Analysis

NASDAQ:CRDO - Nasdaq - KYG254571055 - Common Stock - Currency: USD

85.51  -0.08 (-0.09%)

Premarket: 85.55 +0.04 (+0.05%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CRDO. CRDO was compared to 110 industry peers in the Semiconductors & Semiconductor Equipment industry. No worries on liquidiy or solvency for CRDO as it has an excellent financial health rating, but there are worries on the profitability. CRDO shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

CRDO had positive earnings in the past year.
CRDO had a positive operating cash flow in the past year.
In the past 5 years CRDO reported 4 times negative net income.
CRDO had negative operating cash flow in 4 of the past 5 years.
CRDO Yearly Net Income VS EBIT VS OCF VS FCFCRDO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M

1.2 Ratios

CRDO has a Return On Assets (0.71%) which is comparable to the rest of the industry.
CRDO's Return On Equity of 0.83% is in line compared to the rest of the industry. CRDO outperforms 47.27% of its industry peers.
Industry RankSector Rank
ROA 0.71%
ROE 0.83%
ROIC N/A
ROA(3y)-0.81%
ROA(5y)-5.2%
ROE(3y)-0.78%
ROE(5y)-5.66%
ROIC(3y)N/A
ROIC(5y)N/A
CRDO Yearly ROA, ROE, ROICCRDO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 5 -5 -10 -15

1.3 Margins

CRDO's Profit Margin of 1.56% is in line compared to the rest of the industry. CRDO outperforms 50.00% of its industry peers.
CRDO's Operating Margin has improved in the last couple of years.
CRDO's Gross Margin of 63.72% is amongst the best of the industry. CRDO outperforms 89.09% of its industry peers.
In the last couple of years the Gross Margin of CRDO has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 1.56%
GM 63.72%
OM growth 3YN/A
OM growth 5Y17.38%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.53%
GM growth 5Y-5.44%
CRDO Yearly Profit, Operating, Gross MarginsCRDO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60 80

8

2. Health

2.1 Basic Checks

CRDO does not have a ROIC to compare to the WACC, probably because it is not profitable.
CRDO has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CRDO has been increased compared to 5 years ago.
There is no outstanding debt for CRDO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CRDO Yearly Shares OutstandingCRDO Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 50M 100M 150M
CRDO Yearly Total Debt VS Total AssetsCRDO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 86.77 indicates that CRDO is not in any danger for bankruptcy at the moment.
CRDO's Altman-Z score of 86.77 is amongst the best of the industry. CRDO outperforms 98.18% of its industry peers.
CRDO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 86.77
ROIC/WACCN/A
WACC10.17%
CRDO Yearly LT Debt VS Equity VS FCFCRDO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 7.67 indicates that CRDO has no problem at all paying its short term obligations.
CRDO has a better Current ratio (7.67) than 90.00% of its industry peers.
A Quick Ratio of 7.01 indicates that CRDO has no problem at all paying its short term obligations.
CRDO's Quick ratio of 7.01 is amongst the best of the industry. CRDO outperforms 90.91% of its industry peers.
Industry RankSector Rank
Current Ratio 7.67
Quick Ratio 7.01
CRDO Yearly Current Assets VS Current LiabilitesCRDO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 200M 400M 600M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 688.89% over the past year.
CRDO shows a strong growth in Revenue. In the last year, the Revenue has grown by 126.34%.
CRDO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 52.02% yearly.
EPS 1Y (TTM)688.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%400%
Revenue 1Y (TTM)126.34%
Revenue growth 3Y60.07%
Revenue growth 5Y52.02%
Sales Q2Q%179.73%

3.2 Future

Based on estimates for the next years, CRDO will show a very strong growth in Earnings Per Share. The EPS will grow by 35.98% on average per year.
Based on estimates for the next years, CRDO will show a very strong growth in Revenue. The Revenue will grow by 34.80% on average per year.
EPS Next Y120.27%
EPS Next 2Y66.78%
EPS Next 3Y35.98%
EPS Next 5YN/A
Revenue Next Year90.06%
Revenue Next 2Y52.57%
Revenue Next 3Y34.8%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CRDO Yearly Revenue VS EstimatesCRDO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
CRDO Yearly EPS VS EstimatesCRDO Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 0 0.5 1 1.5

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 120.44, which means the current valuation is very expensive for CRDO.
Compared to the rest of the industry, the Price/Earnings ratio of CRDO indicates a slightly more expensive valuation: CRDO is more expensive than 60.00% of the companies listed in the same industry.
CRDO is valuated expensively when we compare the Price/Earnings ratio to 26.34, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 54.68, CRDO can be considered very expensive at the moment.
The rest of the industry has a similar Price/Forward Earnings ratio as CRDO.
CRDO is valuated expensively when we compare the Price/Forward Earnings ratio to 21.03, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 120.44
Fwd PE 54.68
CRDO Price Earnings VS Forward Price EarningsCRDO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CRDO is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 991.08
CRDO Per share dataCRDO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

CRDO's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CRDO's earnings are expected to grow with 35.98% in the coming years. This may justify a more expensive valuation.
PEG (NY)1
PEG (5Y)N/A
EPS Next 2Y66.78%
EPS Next 3Y35.98%

0

5. Dividend

5.1 Amount

CRDO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CREDO TECHNOLOGY GROUP HOLDI

NASDAQ:CRDO (6/20/2025, 8:26:59 PM)

Premarket: 85.55 +0.04 (+0.05%)

85.51

-0.08 (-0.09%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)06-02 2025-06-02/amc
Earnings (Next)09-02 2025-09-02/amc
Inst Owners76.71%
Inst Owner ChangeN/A
Ins Owners14.74%
Ins Owner Change-2.21%
Market Cap14.52B
Analysts83.16
Price Target86.12 (0.71%)
Short Float %5.88%
Short Ratio1.73
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)31.55%
Min EPS beat(2)29.49%
Max EPS beat(2)33.61%
EPS beat(4)3
Avg EPS beat(4)22.81%
Min EPS beat(4)-4.12%
Max EPS beat(4)33.61%
EPS beat(8)6
Avg EPS beat(8)77.96%
EPS beat(12)9
Avg EPS beat(12)187.46%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)7.99%
Min Revenue beat(2)5.74%
Max Revenue beat(2)10.24%
Revenue beat(4)2
Avg Revenue beat(4)3.11%
Min Revenue beat(4)-1.85%
Max Revenue beat(4)10.24%
Revenue beat(8)5
Avg Revenue beat(8)1.95%
Revenue beat(12)6
Avg Revenue beat(12)1.15%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)27.74%
PT rev (3m)0.84%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)33.95%
EPS NY rev (3m)47.92%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)19.67%
Revenue NY rev (3m)32.48%
Valuation
Industry RankSector Rank
PE 120.44
Fwd PE 54.68
P/S 44.33
P/FCF N/A
P/OCF 1271.64
P/B 23.49
P/tB 23.49
EV/EBITDA 991.08
EPS(TTM)0.71
EY0.83%
EPS(NY)1.56
Fwd EY1.83%
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)0.07
OCFY0.08%
SpS1.93
BVpS3.64
TBVpS3.64
PEG (NY)1
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.71%
ROE 0.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 1.56%
GM 63.72%
FCFM N/A
ROA(3y)-0.81%
ROA(5y)-5.2%
ROE(3y)-0.78%
ROE(5y)-5.66%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y17.38%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.53%
GM growth 5Y-5.44%
F-Score7
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 198.15%
Cap/Sales 10.87%
Interest Coverage N/A
Cash Conversion 80.48%
Profit Quality N/A
Current Ratio 7.67
Quick Ratio 7.01
Altman-Z 86.77
F-Score7
WACC10.17%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)688.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%400%
EPS Next Y120.27%
EPS Next 2Y66.78%
EPS Next 3Y35.98%
EPS Next 5YN/A
Revenue 1Y (TTM)126.34%
Revenue growth 3Y60.07%
Revenue growth 5Y52.02%
Sales Q2Q%179.73%
Revenue Next Year90.06%
Revenue Next 2Y52.57%
Revenue Next 3Y34.8%
Revenue Next 5YN/A
EBIT growth 1Y91.7%
EBIT growth 3YN/A
EBIT growth 5Y78.45%
EBIT Next Year130.09%
EBIT Next 3Y53.19%
EBIT Next 5YN/A
FCF growth 1Y-6253.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-31.79%
OCF growth 3YN/A
OCF growth 5YN/A